Please login to the form below

Not currently logged in
Email:
Password:

Bionor Pharma

This page shows the latest Bionor Pharma news and features for those working in and with pharma, biotech and healthcare.

Celgene's cancer drug promising in small HIV study

Celgene's cancer drug promising in small HIV study

The study was part of a project sponsored by Bionor Pharma, a Norwegian biopharma company that is developing romidepsin alongside its therapeutic vaccine candidate Vacc-4x in a two-part treatment

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • David Horn Solomon takes the helm of Akari Therapeutics David Horn Solomon takes the helm of Akari Therapeutics

    David has a strong track record of leading phase II stage companies like Akari, most notably at Zealand Pharma where he led the development of lixisenatide, which is now commercialised by ... Sanofi.”. His other roles have included CEO at Bionor Pharma

  • Bionor names executive management team additions Bionor names executive management team additions

    Bionor names executive management team additions. Three new starters including chief operating officer and interim CFO. ... HIV and deadly virus firm Bionor Pharma has revealed a number of new additions to its executive management team.

  • Anker Lundemose appointed CEO of Bionor Pharma Anker Lundemose appointed CEO of Bionor Pharma

    Anker Lundemose appointed CEO of Bionor Pharma. Will lead efforts to develop and commercialise HIV vaccines. ... Vaccines specialist Bionor Pharma has appointed Dr Anker Lundemose as its new president and CEO.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics